MF acts as an insulin sensitizing agent resulting in a reduction of hepatic glucose secretion and increase of peripheral glucose utilization with positive effects on IR, body weight, and menstrual cycling in PCOS [30]. Here, INS is linked to polycystic ovary syndrome.